Altay Therapeutics
altaytherapeutics.com
Actively hiring
Oncology Therapeutics
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$15.7M
1 round on record
Latest round
$15.7M
Venture round · Sep 2026 · this month
Backers
2
Y Combinator, HealthCap
The money's age
Fresh money
0 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Tractionpublic signals, read monthly
Web presence
top 13%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Sep 2026 | $15.7M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Altay Therapeutics, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
James BreitmeyerExecutive Officer, DirectorSEC Form D
Ali OzesExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Y Combinator 
HealthCap Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
KAHR Bio: Pioneering Immunotherapeutics for Advanced Cancer Treatment.
Creating neoantigens by design… …to transform cancer treatments into cures. ATP IS DEVELOPING THE NEXT GENERATION OF TRANSFORMATIVE LIFE…
RS & RS Scientific leads in cutting-edge cancer therapy research, developing innovative therapies for challenging cancer treatments. Their…
Innovating life-changing medicines for cancer patients. At Kumquat, we're on a mission to transform cancer treatment by delivering durable…
Alpheus is advancing a new therapeutic approach designed to improve outcomes while reducing treatment burden for patients and families.
Yemaachi is creating the world's most diverse cancer bio-database to develop the next generation of cancer drugs that are effective in…
Overview
Pioneering the first oral drug for FSHD and advancing cancer treatment solutions.
News
$101M XPRIZE HEALTHSPAN AWARDS FIRST MILESTONE WINNERS DRIVING TOWARD REVOLUTIONARY HEALTHY AGING ADVANCES
/PRNewswire/ -- XPRIZE, the world
Read more
Report
People
James Breitmeyer
Executive Officer, Director
Ali Ozes
Executive Officer
Eric Bjerkholt
Director
Mike Grey
Director
Ester Sklarsky
Director
Aidan King
Director
Chelsea Johnson
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Carlos
United States
HQ
Financials
Total raised
$15.7M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2026 | $15.7M | Details |